Cefamandole prophylaxis for cardiovascular surgery: a dosage comparison

Area of Science:

• Infectious Diseases
• Surgical Prophylaxis
• Pharmacology

Background:

• Antibiotic prophylaxis is crucial for preventing surgical site infections in open-heart operations.
• Cefamandole has been a standard antibiotic for surgical prophylaxis due to its broad spectrum and low toxicity.
• Recent concerns exist regarding the adequacy of standard cefamandole dosing for maintaining intraoperative tissue levels.

Purpose of the Study:

• To evaluate the efficacy of a higher cefamandole dosage regimen (2.0 g every 6 hours for two days) compared to the standard regimen (1.0 g every 6 hours for three days) in preventing infections after open-heart surgery.
• To assess the cost-effectiveness of the higher cefamandole dosage.

Main Methods:

• A randomized study involving 211 evaluable open-heart surgery patients without prior infections or cephalosporin allergy.
• Patients received either the standard 1.0 g or the higher 2.0 g intravenous cefamandole dose.
• Infection rates, tissue levels, and cardiopulmonary bypass time were analyzed.

Main Results:

• No statistically significant difference in surgery-related or nosocomial infections was observed between the 1.0-g and 2.0-g cefamandole dose groups (3.5% vs 3.9% and 3.5% vs 3.9%, respectively).
• Intraoperative cefamandole tissue levels and cardiopulmonary bypass pump time were not identified as risk factors for infection.
• The 2.0-g dosing regimen was found to be more economical when considering administration fees.

Conclusions:

• The higher cefamandole dosage (2.0 g every 6 hours for two days) is not more effective than the standard dosage (1.0 g every 6 hours for three days) in reducing infectious complications after open-heart surgery.
• The 2.0-g dosing regimen offers a more cost-effective alternative to the standard regimen.